Automating Critical Drug Discovery Processes with NLP - with Emmanuel Walckenaer of YSEOP

Automating Critical Drug Discovery Processes with NLP - with Emmanuel Walckenaer of YSEOP

0 Hinnangud
0
Osa
531 of 1058
Kestus
28 min
Keel
inglise
Vorming
Kategooria
Majandus ja ettevõtlus

Today's guest is Emmanuel Walckenaer, CEO of YSEOP. A firm based in Paris, YSEOP focuses on natural language generation across financial services and life sciences industries. Emmanuel speaks with us this week about the applications of NLG when it comes to drug discovery and life sciences. Emmanuel also discusses some other life sciences and AI trends that he thinks are promising and some of the trends that he's seen in his work in the life sciences space. This episode is sponsored by YSEOP. If you're interested in reaching the Emerj audience, you have an important educational message about use-cases and applications of AI, be sure to contact us at emerj.com/ad1.


Loe ja kuula

Astu lugude lõputusse maailma

  • Suurim valik eestikeelseid audio- ja e-raamatuid
  • Proovi tasuta
  • Loe ja kuula nii palju, kui soovid
  • Lihtne igal ajal tühistada
Device Banner Block-copy 894x1036
Cover for Automating Critical Drug Discovery Processes with NLP - with Emmanuel Walckenaer of YSEOP

Muud podcastid, mis võivad sulle meeldida ...